Unlike C-11 choline, which is primarily used for bone metastasis detection, F-18 FCH has been approved for evaluating both soft tissues in cases of BCR or disease progression and for the early detection of bone metastasis, particularly when serum PSA levels exceed 1.0 ng/mL [5,32,33]. This evidence concerns the gene BCR and bone metastasis.